Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Recruiting NCT05673304

Preoperative Boost Associated With Neoadjuvant Chemotherapy in Luminal B Breast Cancer

Conditions: Breast Cancer, Radiotherapy

Sex: Female

Ages: 18 Years – N/A

Phase: NA

Enrollment: 30

Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna

Location: Italy

Summary

IBISCO TRIAL is a phase II trial aimed to demonstrate the improvement of pathological complete response (pCR) in Luminal B breast cancer (BC) patients treated with stereotactic radiation therapy (SBRT) as an anticipated boost associated with neoadjuvant chemotherapy (NAC).As a secondary objective, histochemical and molecular analysis of the tumour and the inflammatory microenvironment will be performed.

Eligibility Criteria

Inclusion Criteria:Luminal B-like BC, cT1-2Indication for neoadjuvant chemotherapyExclusion Criteria:PregnancyBreast feedingPatient not available for follow up

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05673304). StuddyBuddy aggregates publicly available trial information.